abstract |
The invention relates to compounds of Formula (I) n n n n n n n n n n and pharmaceutically acceptable acid addition salts thereof, wherein *, X 1 , X 2 , R 5A , R 5B , R 6 , R 7 , and R 8 are as defined in the specification; pharmaceutical compositions; therapeutic combinations; and methods of treating diseases and disorders. |